万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://www.journals.elsevier.com/neoplasia/
3、投稿网址：
https://www.editorialmanager.com/neo/default.aspx
4、官网邮箱：neoplasia@elsevier.com
5、期刊刊期：月刊，一年出版十二期。
2021年5月21日星期五
投稿须知【官网信息】
Guide for Authors
Scope and Mission
Neoplasia publishes the results of novel investigations in all areas of oncology research. The title Neoplasia was chosen to convey the journal’s breadth, which encompasses the traditional disciplines of cancer research as well as emerging fields and interdisciplinary investigations. Neoplasia is interested in studies describing new molecular and genetic findings relating to the neoplastic phenotype and in laboratory and clinical studies demonstrating creative applications of advances in the basic sciences to risk assessment, prognostic indications, detection, diagnosis, and treatment. In addition to regular Research Reports, Neoplasia also publishes Reviews and Meeting Reports. Neoplasia is committed to ensuring a thorough, fair, and rapid review and publication schedule to further its mission of serving both the scientific and clinical communities by disseminating important data and ideas in cancer research. Neoplasia encourages the free exchange of all clones, cell lines, and biological reagents described in its pages to facilitate the progress of research in order to ultimately provide those fighting neoplastic diseases with new diagnostic, preventative and therapeutic options.
Peer Review
The Editors are committed to a rapid review process with high quality standards. Every effort will be made to obtain reviews and return editorial decisions to the authors within 3 weeks of manuscript receipt. When manuscripts are accepted contingent on revision, the revised work must be received within three months of the decision date, unless prior arrangements are made with the Editors.
Guidelines for Editorial Decisions
The primary criteria for judging which manuscripts are published are originality and scientific/clinical significance. Manuscripts may be editorially declined on these grounds, even if the experimental work appears technically sound.
Prior Publication
The submitted material must not be published nor submitted elsewhere, except in abstract form.
Your Paper Your Way
We now differentiate between the requirements for new and revised submissions. You may choose to submit your manuscript as a single Word or PDF file to be used in the refereeing process. Only when your paper is at the revision stage, will you be requested to put your paper in to a 'correct format' for acceptance and provide the items required for the publication of your article.
To find out more, please visit the Preparation section below.
Types of Articles
Neoplasia publishes material in the form of original articles, review articles, opinions, short communications such as spotlights, previews and perspectives, and letters to the editor.
Original Research Article
Original, full-length research articles which have not been published previously, except in a preliminary form, may be submitted. Original Studies present results of original basic and translational research.
Mechanics: Original research articles should include a structured abstract and should be divided into sections (Introduction, Materials and Methods, Results and Discussion). Original research articles have a limit of 4,500 words and no more than 50 references. Authors are asked to limit the number of figures and/or tables to 6.
Reviews and Opinions
Review Article
Review articles offer a balanced account of newly emerging or rapidly progressing fields and provide a guide to the most relevant recent literature and prospects for future research.
They should briefly set the background and then concentrate on setting recent findings in context. It is crucial that they should give a balanced view of developments, even in fields that are controversial, and authors must never concentrate unduly on their own research. Although Reviews do allow room for some speculation and debate, it should be made clear where the authors' own opinions are being presented.
References selected for publication should be chosen for their importance, ease of access, and for the "further reading" opportunities they provide; citations to papers published in non-peer-reviewed supplements are discouraged.
Mechanics: Reviews articles should contain a short abstract stating the goal of the review, an introduction, discussion, and conclusion. Reviews have a limit of 4,500 words and no more than 80 references. Authors are asked to limit the number of figures and/or tables to 6. Reviews should have no more than 5 authors without prior agreement of the editors.
Opinion article
Opinions may reflect an individual perception, involvement, or contribution to oncology, and should be prepared in a similar way to a Review. Opinions should present a personal and original perspective on an important research-related topic of interest to the cancer research community, rather than a balanced review of this topic.
The aim should be to stimulate debate or new research, cover controversial topics, or provide a new framework for, or interpretation of, an old problem or current issue, or speculate on the implications of some recent research. Although Opinion articles can be more 'forward looking' than Reviews, please avoid being overly speculative. Please note that articles that outline recent advances in a field rather than give a strong opinion on them are not suitable for this section of the journal; neither are hypotheses without any published support.
Mechanics: Opinion articles have a limit of 2,500 words and no more than 60 references. Authors are asked to limit the number of figures and/or tables to 6. Opinions should have no more than 3 authors without prior approval from the editors. Opinions should include an abstract.
Short Communications
Spotlights
Spotlights are short articles intended to provide a quick update on one or two recent research articles published in other journals that signify a major advancement in a specific field of Cancer. Spotlights should give additional insight on the topic, highlighting broader implications for the field that have not already been provided by the original paper(s). Although subjective, Spotlight articles should not be used to dwell excessively on the author's own research, to introduce new (unpublished) data, or to excessively criticize the work of others, except where criticism is constructive.
Please send a pre-submission inquiry to the Journal Inbox: neoplasia@elsevier.com
Mechanics: Spotlights have a limit of 1,500 words and no more than 10 references. Authors are asked to limit the number of figures and/or tables to 2. Spotlights should include an abstract.
Commentaries
Commentaries are short articles that highlight one or several research papers published in a recent issue of the Journal, placing the results in context for the Journal's broad readership. Commentaries are commissioned by the editors to accompany new papers in Neoplasia. Unsolicited contributions are not considered.
Mechanics: Commentaries have a limit of 1,500 words and no more than 10 references. Authors are asked to limit the number of figures and/or tables to 2. Commentaries should include an abstract.
Perspectives
Perspectives are short pieces that aim to highlight for a very broad audience a significant recent development in the field or to raise awareness about a topic of general interest. Possible topics can include future outlook essays that serve to introduce or encourage research in a new field, reflections and new insights on long-standing questions and debates, and general analyses of common scientific practices or tools used in a field.
Perspectives should not include unpublished data, simulations, or meta-analyses. Although subjective, a perspective should not be used to dwell excessively on the author's own research or to excessively criticize the research of others, except where criticism is constructive. The introduction of hypothesis and models is encouraged, and the articles should be written with a very personal perspective, but it is important to mention other viewpoints where they exist to place the work discussed in a context for the nonspecialist reader.
Please send a pre-submission inquiry to the Journal Inbox: neoplasia@elsevier.com
Mechanics: Perspectives have a limit of 1,200 words and no more than 10 references. Authors are asked to limit the number of figures and/or tables to 2. Perspectives should have no more than 3 authors without prior approval from the editors. Perspectives should include an abstract. Case Reports
NEO does not publish Case Reports. You may consider submitting your case report to Current Problems in Cancer: Case Reports, a Journal which aims to fortify the field of oncology by publishing original case reports featuring prevention, diagnosis and treatment of cancer, supportive care, quality of life and rehabilitation.
Letters to the Editors
Letters to the Editors which comment directly on work that has previously been published in the Journal will be considered. The author of the paper on which the Letter is commenting will be contacted and invited to respond.
Mechanics: Letters have a limit of 1,000 words and no more than 10 references. Authors are asked to limit the number of figures and/or tables to 1. Letters should not include an abstract or have more than 3 authors without prior approval from the editors.
Editorials
Editorials serve as the voice of Neoplasia and are written by the Journal's Editors and Guest Editors.
Ethics in publishing
Please see our information pages on Ethics in publishing and Ethical guidelines for journal publication.
Studies in humans and animals
If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly.
Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
All animal experiments should comply with the ARRIVE guidelines and should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments, or the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978) and the authors should clearly indicate in the manuscript that such guidelines have been followed. The sex of animals must be indicated, and where appropriate, the influence (or association) of sex on the results of the study.
Informed consent and patient details
Studies on patients or volunteers require ethics committee approval and informed consent, which should be documented in the paper. Appropriate consents, permissions and releases must be obtained where an author wishes to include case details or other personal information or images of patients and any other individuals in an Elsevier publication. Written consents must be retained by the author but copies should not be provided to the journal. Only if specifically requested by the journal in exceptional circumstances (for example if a legal issue arises) the author must provide copies of the consents or evidence that such consents have been obtained. For more information, please review the Elsevier Policy on the Use of Images or Personal Information of Patients or other Individuals. Unless you have written permission from the patient (or, where applicable, the next of kin), the personal details of any patient included in any part of the article and in any supplementary materials (including all illustrations and videos) must be removed before submission.
Declaration of competing interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors should complete the declaration of competing interest statement using this template and upload to the submission system at the Attach/Upload Files step. Note: Please do not convert the .docx template to another file type. Author signatures are not required. If there are no interests to declare, please choose the first option in the template. More information.
Submission declaration and verification
Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.
Preprints
Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).
Use of inclusive language
Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.
Author contributions
For transparency, we encourage authors to submit an author statement file outlining their individual contributions to the paper using the relevant CRediT roles: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration; Resources; Software; Supervision; Validation; Visualization; Roles/Writing - original draft; Writing - review & editing. Authorship statements should be formatted with the names of authors first and CRediT role(s) following. More details and an example
Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.
Article Transfer Service
Neoplasia is part of our Article Transfer Service. This means that if the Editor feels your manuscript is more suitable for one of the other participating journals, then you may be offered the opportunity to transfer your submission to one of those. If you agree, your article will then be transferred on your behalf with no need to reformat, and your article will be reviewed by the other journal. More information can be found here: https://www.elsevier.com/authors/article-transfer-service.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'License Agreement' (see more information on this). Permitted third party reuse of open access articles is determined by the author's choice of user license.
Author rights
As an author you (or your employer or institution) have certain rights to reuse your work. More information.
Sequence Data
GenBank/EMBL/DDBJ database accession numbers are required for all new sequences before they can be published in Neoplasia. Sequence data should be sent to GenBank before the manuscript is submitted for review. If the number is not available at the time of submission, it can be added at the page-proof stage.
Elsevier supports responsible sharing
Find out how you can share your research published in Elsevier journals.
Role of the funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.
Open access
Please visit our Open Access page for more information.
Language (usage and editing services)
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier's WebShop. Please note the journal also offers complimentary language editing at the discretion of the editor.
Submission
Our online submission system guides you stepwise through the process of entering your article details and uploading your files. The system converts your article files to a single PDF file used in the peer-review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for final publication. All correspondence, including notification of the Editor's decision and requests for revision, is sent by e-mail.
Submit your article
Please submit your article via https://www.editorialmanager.com/NEO.
NEW SUBMISSIONS
Submission to this journal proceeds totally online and you will be guided stepwise through the creation and uploading of your files. The system automatically converts your files to a single PDF file, which is used in the peer-review process.
As part of the Your Paper Your Way service, you may choose to submit your manuscript as a single file to be used in the refereeing process. This can be a PDF file or a Word document, in any format or lay-out that can be used by referees to evaluate your manuscript. It should contain high enough quality figures for refereeing. If you prefer to do so, you may still provide all or some of the source files at the initial submission. Please note that individual figure files larger than 10 MB must be uploaded separately.
References
There are no strict requirements on reference formatting at submission. References can be in any style or format as long as the style is consistent. Where applicable, author(s) name(s), journal title/book title, chapter title/article title, year of publication, volume number/book chapter and the article number or pagination must be present. Use of DOI is highly encouraged. The reference style used by the journal will be applied to the accepted article by Elsevier at the proof stage. Note that missing data will be highlighted at proof stage for the author to correct.
Formatting requirements
There are no strict formatting requirements but all manuscripts must contain the essential elements needed to convey your manuscript, for example Abstract, Keywords, Introduction, Materials and Methods, Results, Conclusions, Artwork and Tables with Captions.
If your article includes any Videos and/or other Supplementary material, this should be included in your initial submission for peer review purposes.
Divide the article into clearly defined sections.
Figures and tables embedded in text
Please ensure the figures and the tables included in the single file are placed next to the relevant text in the manuscript, rather than at the bottom or the top of the file. The corresponding caption should be placed directly below the figure or table.
Peer review
This journal operates a single anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final. Editors are not involved in decisions about papers which they have written themselves or have been written by family members or colleagues or which relate to products or services in which the editor has an interest. Any such submission is subject to all of the journal's usual procedures, with peer review handled independently of the relevant editor and their research groups. More information on types of peer review.
REVISED SUBMISSIONS
Use of word processing software
Regardless of the file format of the original submission, at revision you must provide us with an editable file of the entire article. Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. The electronic text should be prepared in a way very similar to that of conventional manuscripts (see also the Guide to Publishing with Elsevier). See also the section on Electronic artwork.
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check' functions of your word processor.
Article structure
Subdivision - unnumbered sections
Divide your article into clearly defined sections. Each subsection is given a brief heading. Each heading should appear on its own separate line. Subsections should be used as much as possible when cross-referencing text: refer to the subsection by heading as opposed to simply 'the text'.
Introduction
State the objectives of the work and provide an adequate background, avoiding a detailed literature survey or a summary of the results.
Material and methods
Provide sufficient details to allow the work to be reproduced by an independent researcher. Methods that are already published should be summarized, and indicated by a reference. If quoting directly from a previously published method, use quotation marks and also cite the source. Any modifications to existing methods should also be described.
……
更多详情：
https://www.elsevier.com/journals/neoplasia/1476-5586/guide-for-authors
